Cancer has many escape routes, but we’re closing off some important ones.

Blocking Escape
to Stop Cancer

Anji Onco, a subsidiary of Anji Pharma, is laser-focused on blocking escape routes cancer uses to evade therapeutic intervention. These survival mechanisms - from amplifying a gene that promotes cancer survival, to displaying proteins that cloak cancer cells and hide them from the immune system - diminish the efficacy of even the most powerful anti-cancer drugs. Our unwavering belief is that resistance can be overcome.

For partnerships, investment opportunities, or to learn more about our work, contact us.